646 related articles for article (PubMed ID: 19559453)
1. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins.
Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G
Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453
[TBL] [Abstract][Full Text] [Related]
2. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
Colombage G; Hall R; Pavy M; Lobigs M
Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
[TBL] [Abstract][Full Text] [Related]
3. A Vero cell-attenuated Goatpox virus provides protection against virulent virus challenge.
Hosamani M; Nandi S; Mondal B; Singh RK; Rasool TJ; Bandyopadhyay SK
Acta Virol; 2004; 48(1):15-21. PubMed ID: 15230470
[TBL] [Abstract][Full Text] [Related]
4. Construction of an attenuated goatpox virus AV41 strain by deleting the TK gene and ORF8-18.
Zhu Y; Li Y; Bai B; Fang J; Zhang K; Yin X; Li S; Li W; Ma Y; Cui Y; Wang J; Liu X; Li X; Sun L; Jin N
Antiviral Res; 2018 Sep; 157():111-119. PubMed ID: 30030019
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
6. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
Chen ZH; Guo X; Ge XN; Jia H; Yang HC
Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
[TBL] [Abstract][Full Text] [Related]
7. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
8. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
Yu YZ; Zhang SM; Sun ZW; Wang S; Yu WY
Vaccine; 2007 Dec; 25(52):8843-50. PubMed ID: 18022294
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
10. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
[TBL] [Abstract][Full Text] [Related]
11. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.
Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ
Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens.
Mahmood MS; Hussain I; Siddique M; Akhtar M; Ali S
Vaccine; 2007 Nov; 25(44):7629-35. PubMed ID: 17913306
[TBL] [Abstract][Full Text] [Related]
13. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
[TBL] [Abstract][Full Text] [Related]
14. A vaccination strategy consisting of Semliki-Forest-virus (SFV) DNA prime and fowlpox-virus boost significantly protects mice from a recombinant (HIV-1) vaccinia-virus infection.
Quintana-Vázquez D; Vázquez-Blomquist DM; Galbán Rodríguez E; Herrera Buch AM; Duarte Cano CA
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):59-66. PubMed ID: 15099194
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
Vanderzanden L; Bray M; Fuller D; Roberts T; Custer D; Spik K; Jahrling P; Huggins J; Schmaljohn A; Schmaljohn C
Virology; 1998 Jun; 246(1):134-44. PubMed ID: 9657001
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
[TBL] [Abstract][Full Text] [Related]
17. A bivalent vaccine against goat pox and Peste des Petits ruminants induces protective immune response in goats.
Hosamani M; Singh SK; Mondal B; Sen A; Bhanuprakash V; Bandyopadhyay SK; Yadav MP; Singh RK
Vaccine; 2006 Aug; 24(35-36):6058-64. PubMed ID: 16828938
[TBL] [Abstract][Full Text] [Related]
18. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
[TBL] [Abstract][Full Text] [Related]
20. Enhancing immune responses using suicidal DNA vaccines.
Berglund P; Smerdou C; Fleeton MN; Tubulekas I; Liljeström P
Nat Biotechnol; 1998 Jun; 16(6):562-5. PubMed ID: 9624688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
